Girard, N.;                     Besada, M.;                     Rogula, B.;                     Lucherini, S.;                     Vo, L.;                     Chaudhary, M.A.;                     Goring, S.;                     Lozano-Ortega, G.;                     Tran, M.;                     Varol, N.;     
    et al.    Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492.
    https://doi.org/10.3390/cancers16132492
    AMA Style
    
                                Girard N,                                 Besada M,                                 Rogula B,                                 Lucherini S,                                 Vo L,                                 Chaudhary MA,                                 Goring S,                                 Lozano-Ortega G,                                 Tran M,                                 Varol N,         
        et al.        Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers. 2024; 16(13):2492.
        https://doi.org/10.3390/cancers16132492
    
    Chicago/Turabian Style
    
                                Girard, Nicolas,                                 Mariam Besada,                                 Basia Rogula,                                 Stefano Lucherini,                                 Lien Vo,                                 Mohammad A. Chaudhary,                                 Sarah Goring,                                 Greta Lozano-Ortega,                                 Mia Tran,                                 Nebibe Varol,         
         and et al.        2024. "Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis" Cancers 16, no. 13: 2492.
        https://doi.org/10.3390/cancers16132492
    
    APA Style
    
                                Girard, N.,                                 Besada, M.,                                 Rogula, B.,                                 Lucherini, S.,                                 Vo, L.,                                 Chaudhary, M. A.,                                 Goring, S.,                                 Lozano-Ortega, G.,                                 Tran, M.,                                 Varol, N.,                                 Waser, N.,                                 Yu, W. W.,                                 Lee, J. M.,                                 & Spicer, J.        
        
        (2024). Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers, 16(13), 2492.
        https://doi.org/10.3390/cancers16132492